Related Experiment Video
Updated: May 16, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
[Estimation of the risk of upper digestive tract bleeding in patients with portal cavernomatosis]
Insights
Children diagnosed with portal cavernoma face a significant risk of upper gastrointestinal bleeding (UGB). In this study, 77% experienced UGB, with a median time to first bleed of 314 days.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Vascular Malformations
Context:
- Portal cavernoma, a rare vascular malformation of the portal vein, can lead to serious complications in children.
- Upper gastrointestinal bleeding (UGB) is a primary concern in pediatric patients with portal cavernoma.
- Limited data exists on the incidence and risk factors of UGB in this specific pediatric population.
Purpose:
- To determine the risk of upper gastrointestinal bleeding (UGB) in children diagnosed with portal cavernoma.
- To identify potential risk factors associated with UGB in pediatric portal cavernoma cases.
- To analyze the incidence rate and survival time until the first bleeding event.
Summary:
- A retrospective analysis of 13 pediatric portal cavernoma cases was conducted.
- The study found a high incidence of UGB (77%) with a median time to first bleed of 314 days.
- No statistically significant association was found between studied parameters (age, platelets, leukocytes, hemoglobin, hematocrit, prothrombin time) and UGB risk.
Impact:
- Provides crucial data on the high risk of UGB in children with portal cavernoma.
- Highlights the need for vigilant monitoring and management strategies for these patients.
- Suggests further research is needed to identify predictive factors for bleeding events.
Purpose:
The aim of this study is to find out the risk of upper gastrointestinal bleeding (UGB) after the diagnosis of portal cavernoma in children, and to investigate several potential risk factors.
Material And Methods:
We analyzed retrospectively 13 cases of portal cavernoma and estimated the risk of UGB with the Kaplan-Meier survival analysis. We calculated the incidence rate of the sample and the number of haemorrhages per year for each patient individually. From the moment of the diagnosis various parameters were recorded: age, platelets, leukocytes, hemoblobin, hematocrit, prothrombin time and number of bleedings. The relation between these parameters and the risk of bleeding was assessed with the Cox analysis.
Results:
The patients were followed for a median period of 7.1 years. 10 patients (77%) presented at least 1 episode of UGB after the diagnosis. The median survival time until the first haemorrhage was 314 days. After the diagnosis the incidence rate of the sample was 0.43 episodes of upper gastrointestinal bleeding per person-year. The number of individual bleedings per person had a range of 0-2.2 episodes per year.
Conclusions:
There is very few data about the risk of bleeding in children with portal cavernoma. In our sample, we found out an incidence rate of 0.43 and a median survival time of 314 days until the first episode of bleeding after the diagnosis, but we were not able to find a statistically significant association between the studied variables and the risk of bleeding.
Related Concept Videos
Esophageal Varices-I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Portal Hypertension
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer
